×

Pharmaceutical composition for treatment of dry eye syndrome

  • US 8,614,178 B2
  • Filed: 12/13/2010
  • Issued: 12/24/2013
  • Est. Priority Date: 12/14/2009
  • Status: Active Grant
First Claim
Patent Images

1. A pharmaceutical composition comprising:

  • (a) a therapeutically effective amount of an active ingredient selected from the group of macrolide immunosuppressants useful in the prevention or therapy of keratoconjunctivitis sicca or a symptom associated therewith, and(b) liquid vehicle comprising a semifluorinated alkane, wherein the pharmaceutical composition is formulated as a clear solution.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×